In addition to being redundant, Tidmarsh said, advisory meetings on specific drugs were “a tremendous amount of work for the company and for the FDA. The FDA has held only seven advisory committee meetings since Trump reentered the White House, compared with 22 over the same time frame last year. SUPPORTBefore becoming commissioner, Makary pushed for more advisory committee meetings. Please message KFF Health News on Signal at (415) 519-8778 or get in touch here. This article first appeared on KFF Health News and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License.